Related references
Note: Only part of the references are listed.Impact of Hormonal Therapy on Intermediate Risk Prostate Cancer Treated With Combination Brachytherapy and External Beam Irradiation
Richard G. Stock et al.
JOURNAL OF UROLOGY (2010)
PROGNOSTIC SIGNIFICANCE OF 5-YEAR PSA VALUE FOR PREDICTING PROSTATE CANCER RECURRENCE AFTER BRACHYTHERAPY ALONE AND COMBINED WITH HORMONAL THERAPY AND/OR EXTERNAL BEAM RADIOTHERAPY
Richard G. Stock et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Biochemical Control and Toxicity after Intensity-Modulated Radiation Therapy for Prostate Cancer
Stanley L. Liauw et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2009)
Radical prostatectomy for clinically localized, high risk prostate cancer: Critical analysis of risk assessment methods
Ofer Yossepowitch et al.
JOURNAL OF UROLOGY (2007)
Long-term outcomes after treatment with brachytherapy and supplemental conformal radiation for prostate cancer patients having intermediate and high-risk features
Michael Dattoli et al.
CANCER (2007)
Whole-pelvis, mini-pelvis, or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial
Mack Roach et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Comparison of biochemical failure definitions for permanent prostate brachytherapy
Deborah A. Kuban et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: Results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial
JW Denham et al.
LANCET ONCOLOGY (2005)
Impact of short course hormonal therapy on overall and cancer specific survival after permanent prostate brachytherapy
DC Beyer et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer - A randomized controlled trial
AV D'Amico et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Combined modality treatment in the management of high-risk prostate cancer
RG Stock et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Permanent interstitial brachytherapy for clinically organ-confined high-grade prostate cancer with a pretreatment PSA <20 ng/mL
GS Merrick et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2004)
Combining external beam radiotherapy with prostate brachytherapy: Issues and rationale
C Febles et al.
UROLOGY (2004)
The changing face of low-risk prostate cancer: Trends in clinical presentation and primary management
MR Cooperberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group Protocol 92-02
GE Hanks et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Recommendations for the treatment of localized prostate cancer by permanent interstitial brachytherapy
OW Hakenberg et al.
UROLOGIA INTERNATIONALIS (2003)
The relevance of prostatectomy findings for brachytherapy selection in patients with localized prostate carcinoma
TM Pisansky et al.
CANCER (2002)
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
M Bolla et al.
LANCET (2002)
Failure-free survival following brachytherapy alone or external beam irradiation alone for T1-2 prostate tumors in 2222 patients: Results from a single practice
DG Brachman et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
Palladium-103 brachytherapy for prostate carcinoma
JC Blasko et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)